Systems vaccinology of the BNT162b2 mRNA vaccine in humans (vol 596, pg 410, 2021)

被引:0
|
作者
Arunachalam, Prabhu S.
Scott, Madeleine K. D.
Hagan, Thomas
Li, Chunfeng
Feng, Yupeng
Wimmers, Florian
Grigoryan, Lilit
Trisal, Meera
Edara, Venkata Viswanadh
Lai, Lilin
Chang, Sarah Esther
Feng, Allan
Dhingra, Shaurya
Shah, Mihir
Lee, Alexandra S.
Chinthrajah, Sharon
Sindher, Sayantani B.
Mallajosyula, Vamsee
Gao, Fei
Sigal, Natalia
Kowli, Sangeeta
Gupta, Sheena
Pellegrini, Kathryn
Tharp, Gregory
Maysel-Auslender, Sofia
Hamilton, Sydney
Aoued, Hadj
Hrusovsky, Kevin
Roskey, Mark
Bosinger, Steven E.
Maecker, Holden T.
Boyd, Scott D.
Davis, Mark M.
Utz, Paul J.
Suthar, Mehul S.
Khatri, Purvesh
Nadeau, Kari C.
Pulendran, Bali
机构
[1] Institute for Immunity, Transplantation and Infection, Stanford University, Stanford, CA
[2] Center for Biomedical Informatics, Department of Medicine, Stanford University School of Medicine, Stanford University, Stanford, CA
[3] Division of Infectious Diseases, Cincinnati Children's Hospital Medical Center, Cincinnati, OH
[4] Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, OH
[5] Yerkes National Primate Research Center, Atlanta, GA
[6] Department of Medicine, Division of Immunology and Rheumatology, Stanford University School of Medicine, Stanford University, Stanford, CA
[7] Sean N. Parker Center for Allergy and Asthma Research, Stanford University, Stanford, CA
[8] Quanterix, Billerica, MA
[9] Department of Pathology, Emory University School of Medicine, Atlanta, GA
[10] Department of Pathology, Stanford University School of Medicine, Stanford University, Stanford, CA
[11] Department of Microbiology and Immunology, Stanford University School of Medicine, Stanford University, Stanford, CA
[12] Howard Hughes Medical Institute, Stanford University, Stanford, CA
[13] Department of Medicine, Division of Pulmonary, Allergy and Critical Care Medicine, Stanford University School of Medicine, Stanford University, Stanford, CA
[14] Institute for Immunity, Transplantation and Infection, Stanford University, Stanford, CA
[15] Department of Pathology, Stanford University School of Medicine, Stanford University, Stanford, CA
[16] Department of Microbiology and Immunology, Stanford University School of Medicine, Stanford University, Stanford, CA
关键词
D O I
10.1038/s41586-023-05977-x
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
[No abstract available]
引用
收藏
页码:E18 / E18
页数:1
相关论文
共 50 条
  • [21] Fourth Dose of BNT162b2 mRNA Covid-19 Vaccine
    Tumminia, Andrea
    Romano, Marcello
    NEW ENGLAND JOURNAL OF MEDICINE, 2022, 387 (02) : 191 - 191
  • [22] BNT162b2 mRNA COVID-19 Vaccine: First Approval
    Yvette N. Lamb
    Drugs, 2021, 81 : 495 - 501
  • [23] Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine
    Skowronski, Danuta M.
    De Serres, Gaston
    NEW ENGLAND JOURNAL OF MEDICINE, 2021, 384 (16) : 1576 - 1577
  • [24] Immunogenicity of standard and extended dosing intervals of BNT162b2 mRNA vaccine
    Payne, Rebecca P.
    Longet, Stephanie
    Austin, James A.
    Skelly, Donal T.
    Dejnirattisai, Wanwisa
    Adele, Sandra
    Meardon, Naomi
    Faustini, Sian
    Al-Taei, Saly
    Moore, Shona C.
    Tipton, Tom
    Hering, Luisa M.
    Angyal, Adrienn
    Brown, Rebecca
    Nicols, Alexander R.
    Gillson, Natalie
    Dobson, Susan L.
    Amini, Ali
    Supasa, Piyada
    Cross, Andrew
    Bridges-Webb, Alice
    Reyes, Laura Silva
    Linder, Aline
    Sandhar, Gurjinder
    Kilby, Jonathan A.
    Tyerman, Jessica K.
    Altmann, Thomas
    Hornsby, Hailey
    Whitham, Rachel
    Phillips, Eloise
    Malone, Tom
    Hargreaves, Alexander
    Shields, Adrian
    Saei, Ayoub
    Foulkes, Sarah
    Stafford, Lizzie
    Johnson, Sile
    Wootton, Daniel G.
    Conlon, Christopher P.
    Jeffery, Katie
    Matthews, Philippa C.
    Frater, John
    Deeks, Alexandra S.
    Pollard, Andrew J.
    Brown, Anthony
    Rowland-Jones, Sarah L.
    Mongkolsapaya, Juthathip
    Barnes, Eleanor
    Hopkins, Susan
    Hall, Victoria
    CELL, 2021, 184 (23) : 5699 - +
  • [26] Beyond neutralization for BNT162b2 mRNA vaccination
    Damani-Yokota, Payal
    Yeung, Stephen T.
    Khanna, Kamal M.
    CELL HOST & MICROBE, 2021, 29 (07) : 1033 - 1035
  • [27] CoronaVac or BNT162b2 Vaccine as a Third Dose
    Mungmunpuntipantip, Rujittika
    Wiwanitkit, Viroj
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2022, 206 (03) : 360 - 361
  • [28] Boosting BNT162b2 vaccine efficacy in CLL
    Bhat, Seema A.
    Woyach, Jennifer A.
    BLOOD, 2022, 139 (05) : 639 - 640
  • [29] Adaptive immune response to BNT162b2 mRNA vaccine in immunocompromised adolescent patients
    Bader, Guy
    Itan, Michal
    Edry-Botzer, Liat
    Cohen, Hadar
    Haskin, Orly
    Mozer-Glassberg, Yael
    Harel, Liora
    Munitz, Ariel
    Mandelblit, Nufar Marcus
    Gerlic, Motti
    FRONTIERS IN IMMUNOLOGY, 2023, 14
  • [30] What is the immunological response to BNT162b2 mRNA vaccine in immunocompromised patients? Comment
    Silvestris, Nicola
    EBIOMEDICINE, 2021, 74